This article explores the use of AI research agents, specifically within the cited evidence platform, to streamline pharmaccogenomics research. It details the step-by-step process of using a specialized AI agent to analyze gene-drug interactions for metformin, highlighting how AI organizes evidence, generates detailed reports, and assists researchers in refining and exporting findings efficiently while emphasizing the importance of human verification.
Imagine a research question that could instantly activate a specialized AI agent to search evidence, organize findings, and produce a downloadable research report. This is no longer a futuristic concept but a reality with AI-powered research tools like the Pharmaccogenomics research agent inside the cited evidence platform. This article walks you through the complete process of leveraging such AI agents to enhance pharmaccogenomics research.
The journey begins by navigating to the cited evidence website and logging into your account. Upon entering the main dashboard, you access the AI research workspace by selecting "Deep Research and Reading" from the menu. Here, a large search box awaits your research topic, question, or area of interest.
Below the search box, several research modes are available:
For this demonstration, the "Agents" mode is selected to utilize a specialized AI researcher.
Within the agents section, AI researchers are categorized by fields such as literature, bioinformatics, chemistry, healthcare, finance, and writing. You can search for specific agents or install more free agents to expand options.
Since the focus is on medication and genetics, the healthcare category is chosen. Here, specialized agents like the Pharmaccogenomics agent and Clinical Trial Finder are available.
This agent specializes in studying gene-drug interactions, helping researchers understand how genetic differences influence individual responses to medications.
Upon selecting the Pharmaccogenomics agent, it activates and suggests an instruction in the search box. For example, to study metformin—a widely researched diabetes medication—the following prompt is used:
"Using clin PGX analyze gene drug interactions for metformin include CPIC guidelines, alle functions and clinical recommendations."
This prompt clearly specifies:
After submitting the prompt, the system opens the research workspace and initiates the agent. The agent actively searches for relevant information, examines pharmaccogenomic sources, identifies gene-related evidence, and organizes the results.
A research status indicator shows the ongoing process, emphasizing that the output is not an instant paragraph but a comprehensive research workflow.
Once complete, the AI generates a detailed research report that:
Transparency is crucial; for instance, if the agent cannot access a source directly, it explains this and uses alternative reliable sources.
Researchers should carefully read this section to understand how the answer was formulated.
For metformin analysis, the report typically discusses:
If formal CPIC guidance exists, the agent summarizes it. If not, the report clarifies the absence rather than fabricating clinical rules, distinguishing between research evidence and official prescribing guidelines.
Below the report, a question box allows researchers to ask follow-up questions to refine the findings. Examples include:
This feature enables a continuous research conversation, improving output quality without restarting the search.
Once satisfied, researchers can copy, save, or download the report. Opening the report in document view presents it as a formatted paper with export options including PDF, DOCX, Markdown, and QD.
For example, selecting DOCX allows further editing in Microsoft Word, facilitating integration into research drafts.
Despite AI's assistance in collecting and organizing evidence, final research judgment remains the responsibility of the researcher. It is essential to:
The AI-powered Pharmaccogenomics research agent streamlines the complex process of gene-drug interaction studies. By automating evidence search, organization, and report generation, it saves researchers significant time and effort. The ability to refine findings through follow-up questions and export polished reports enhances research productivity.
This technology represents a significant advancement in pharmaccogenomic research workflows, providing a guided starting point for deeper investigation while maintaining the critical role of human expertise in validating and applying findings.
